Megan Iminitoff

Megan completed a Masters of Science at the University of Auckland in 2017 and has since been in the Blewitt Lab at WEHI involved with researching epigenetics at the PWS cluster. She is currently in the final stages of completing her PhD focussed on the epigenetic regulator SMCHD1 as a potential target for therapy of Prader-Willi Syndrome and Schaaf-Yang Syndrome.